{"title":"导航诊断困境:一个病例系列诊断困境在中枢神经系统(CNS)感染解决分子测序","authors":"Sreethish Sasi , Fatma Ben Abid , Maisa Ali , Junais Koleri , Jabeed Parengal , Waleed Awouda , Manal Hamed , Faiha Eltayeb , Andrez Perez-Lopez , Muna Al-Maslamani , Abdullatif Al-Khal , Mohamed Abukhattab","doi":"10.1016/j.hmedic.2025.100202","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Central nervous system (CNS) infections present a significant diagnostic challenge due to their diverse etiologies and the limitations of conventional diagnostic methods. Standard cerebrospinal fluid (CSF) culture and polymerase chain reaction (PCR) assays often fail to identify causative pathogens, particularly in patients who have received prior antimicrobial therapy. The advent of 16S and 18S ribosomal RNA (rRNA) sequencing has revolutionized microbial identification by enabling the detection of a wide range of bacterial and fungal pathogens with high sensitivity and specificity.</div></div><div><h3>Case presentations</h3><div>We present a retrospective case series of six patients with CNS infections that remained undiagnosed using conventional microbiological methods but were successfully identified using molecular sequencing. Clinical presentations, CSF findings, imaging studies, and treatment outcomes were analyzed to assess the impact of 16S/18S rRNA sequencing on diagnosis and patient management.</div></div><div><h3>Discussion</h3><div>Pathogens identified through sequencing included <em>Klebsiella pneumoniae</em>, <em>Moraxella osloensis</em>, <em>Streptococcus intermedius</em>, <em>Candida albicans</em>, <em>Streptococcus pneumoniae</em>, <em>Brucella melitensis</em>, and <em>Brucella abortus</em>. In all cases, sequencing enabled targeted antimicrobial therapy, leading to favorable clinical outcomes. This method proved particularly useful in cases of partially treated bacterial meningitis, fungal CNS infections, and neurobrucellosis, where standard diagnostics failed.</div></div><div><h3>Conclusion</h3><div>Molecular sequencing serves as a powerful diagnostic tool for CNS infections, especially in culture-negative cases. Its implementation enhances pathogen detection, guides appropriate antimicrobial therapy, and improves clinical outcomes. As sequencing technology becomes more accessible, its integration into routine diagnostic workflows may redefine the approach to CNS infection management.</div></div>","PeriodicalId":100908,"journal":{"name":"Medical Reports","volume":"11 ","pages":"Article 100202"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Navigating diagnostic quandaries: A case series of diagnostic dilemmas in central nervous system (CNS) infections resolved by molecular sequencing\",\"authors\":\"Sreethish Sasi , Fatma Ben Abid , Maisa Ali , Junais Koleri , Jabeed Parengal , Waleed Awouda , Manal Hamed , Faiha Eltayeb , Andrez Perez-Lopez , Muna Al-Maslamani , Abdullatif Al-Khal , Mohamed Abukhattab\",\"doi\":\"10.1016/j.hmedic.2025.100202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Central nervous system (CNS) infections present a significant diagnostic challenge due to their diverse etiologies and the limitations of conventional diagnostic methods. Standard cerebrospinal fluid (CSF) culture and polymerase chain reaction (PCR) assays often fail to identify causative pathogens, particularly in patients who have received prior antimicrobial therapy. The advent of 16S and 18S ribosomal RNA (rRNA) sequencing has revolutionized microbial identification by enabling the detection of a wide range of bacterial and fungal pathogens with high sensitivity and specificity.</div></div><div><h3>Case presentations</h3><div>We present a retrospective case series of six patients with CNS infections that remained undiagnosed using conventional microbiological methods but were successfully identified using molecular sequencing. Clinical presentations, CSF findings, imaging studies, and treatment outcomes were analyzed to assess the impact of 16S/18S rRNA sequencing on diagnosis and patient management.</div></div><div><h3>Discussion</h3><div>Pathogens identified through sequencing included <em>Klebsiella pneumoniae</em>, <em>Moraxella osloensis</em>, <em>Streptococcus intermedius</em>, <em>Candida albicans</em>, <em>Streptococcus pneumoniae</em>, <em>Brucella melitensis</em>, and <em>Brucella abortus</em>. In all cases, sequencing enabled targeted antimicrobial therapy, leading to favorable clinical outcomes. This method proved particularly useful in cases of partially treated bacterial meningitis, fungal CNS infections, and neurobrucellosis, where standard diagnostics failed.</div></div><div><h3>Conclusion</h3><div>Molecular sequencing serves as a powerful diagnostic tool for CNS infections, especially in culture-negative cases. Its implementation enhances pathogen detection, guides appropriate antimicrobial therapy, and improves clinical outcomes. As sequencing technology becomes more accessible, its integration into routine diagnostic workflows may redefine the approach to CNS infection management.</div></div>\",\"PeriodicalId\":100908,\"journal\":{\"name\":\"Medical Reports\",\"volume\":\"11 \",\"pages\":\"Article 100202\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949918625000476\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949918625000476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Navigating diagnostic quandaries: A case series of diagnostic dilemmas in central nervous system (CNS) infections resolved by molecular sequencing
Background
Central nervous system (CNS) infections present a significant diagnostic challenge due to their diverse etiologies and the limitations of conventional diagnostic methods. Standard cerebrospinal fluid (CSF) culture and polymerase chain reaction (PCR) assays often fail to identify causative pathogens, particularly in patients who have received prior antimicrobial therapy. The advent of 16S and 18S ribosomal RNA (rRNA) sequencing has revolutionized microbial identification by enabling the detection of a wide range of bacterial and fungal pathogens with high sensitivity and specificity.
Case presentations
We present a retrospective case series of six patients with CNS infections that remained undiagnosed using conventional microbiological methods but were successfully identified using molecular sequencing. Clinical presentations, CSF findings, imaging studies, and treatment outcomes were analyzed to assess the impact of 16S/18S rRNA sequencing on diagnosis and patient management.
Discussion
Pathogens identified through sequencing included Klebsiella pneumoniae, Moraxella osloensis, Streptococcus intermedius, Candida albicans, Streptococcus pneumoniae, Brucella melitensis, and Brucella abortus. In all cases, sequencing enabled targeted antimicrobial therapy, leading to favorable clinical outcomes. This method proved particularly useful in cases of partially treated bacterial meningitis, fungal CNS infections, and neurobrucellosis, where standard diagnostics failed.
Conclusion
Molecular sequencing serves as a powerful diagnostic tool for CNS infections, especially in culture-negative cases. Its implementation enhances pathogen detection, guides appropriate antimicrobial therapy, and improves clinical outcomes. As sequencing technology becomes more accessible, its integration into routine diagnostic workflows may redefine the approach to CNS infection management.